APN-382558

N/A

Report date: 2022/09/21 14:08:35

Base Information

Drug NameAPN-382558
Drug Alias NameAPN-382558
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-CD3
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungAdenocarcinomaSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtreca Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtreca Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungAdenocarcinomaSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A